# A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

> **NCT07669727** · — · NOT_YET_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 140 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DEVICE:** TheraSphere

## Key facts

- **NCT ID:** NCT07669727
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2028-05
- **Final completion:** 2029-05
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07669727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07669727, "A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07669727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*